Drugs / HS-130
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04116710 | Oct 2019 → Aug 2021 | neoplasm | Heat Biologics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HS-130 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04116710 ↗ |
| Modality | Vaccine | “Vaccine derived from irradiated human lung cancer cells expressing the co-stimulatory fusion protein OX40L-Ig” NCT04116710 ↗ |